Skip to content
Open access

KCNE2 upregulation improves cardiac function by inhibiting Smurf1-mediated SERCA2a degradation in diabetic cardiomyopathy in mice

Jul 2026 · Acta Pharmacologica Sinica · Vol 47, pp. 2955 - 2968 · 0 citations · 48 references
Medicine

TL;DR

A novel protective role of KCNE2 is revealed in diabetic hearts and upregulation is proposed as a potential therapeutic strategy for DCM by suppressing Smurf1-mediated polyubiquitination and proteasomal degradation of SERCA2a.

Read PDF

Similar papers

Open access Aug 2026

POU2F1 promotes hypertensive cardiac fibrosis by regulating mitochondrial homeostasis through PINK1/Parkin-dependent mitophagy

A novel role is identified for POU2F1 in hypertensive cardiac fibrosis, demonstrating that it exacerbates disease progression by disrupting mitochondrial homeostasis through transcriptional activation of PINK1, accompanied by alterations consistent with enhanced PINK1/Parkin-mediated mitophagy signaling.

Yong-Bo Ma, Xiao-Zhe Chen, Zi-Xian Liu et al. · 0 citations
Aug 2026

RGS6 drives myocyte loss in the diabetic heart via a KLF4/miR-30e/CaMKII-dependent mechanism.

It is demonstrated that high glucose triggers regulator of G protein signaling 6 (RGS6) up-regulation in both human and murine cardiomyocytes, the hearts of hyperglycemic mice, and cardiac tissue samples from individuals with heart failure and a history of diabetes point to RGS6/KLF4 as key sources of pathogenic cardia...

Abhishek Singh Sengar, Sreemoyee Chakraborti, Anushree Lye et al. · 0 citations
Open access Aug 2026

SRPK3 exacerbates cardiac ischemia/reperfusion injury by regulating KLF3-mTOR/P70 S6K-mediated autophagy.

Myocardial ischemia-reperfusion (I/R) injury remains a leading cause of cardiac dysfunction and mortality worldwide. Serine/arginine-Rich Protein Kinase 3 (SRPK3) is highly expressed in cardiac muscle, yet its specific pathological role in I/R injury has not been fully characterized. In this study, we utilized cardiac-...

Yun Xing, Saiyang Xie, Nan Zhao et al. · 0 citations
Open access Sep 2026

METTL7B attenuates pathological cardiac hypertrophy via m6A-associated regulation of HK3.

Pathological cardiac hypertrophy is a major contributor to heart failure, yet the epitranscriptomic mechanisms that restrain maladaptive remodeling remain incompletely understood. In this study, we investigated the role of METTL7B and its association with m6A-related regulation of HK3 in pathological cardiac hypertroph...

Z. Bao, Zhi-Qiang Liu, Yu-Chun Yang et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.